Immunopathogenesis of myositis

被引:0
作者
Hohlfeld, R [1 ]
机构
[1] MAX PLANCK INST, ABT NEUROIMMUNOL, MARTINSRIED, GERMANY
关键词
dermatomyositis; polymyositis; inclusion body myositis; pathogenesis; CYTOTOXIC T-CELLS; INFLAMMATORY MYOPATHIES; LYMPHOCYTES-T; HUMAN MYOBLASTS; GAMMA; EXPRESSION; MYOTUBES; MUSCLE; RECEPTOR;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
These inflammatory muscular disorders include dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM). One of the characteristic histological features of DM is ''perifascicular atrophy''. Immunohistochemical analyses in DM show deposition of complement proteins in capillaries. The patients probably produce pathological antibodies that react with components of the muscle endothelial cells, thus causing secondary deposition of complement. In contrast, PM is marked by a cellular injury mechanism. The characteristic histological feature is endomysial T cell infiltration, consisting predominantly of CD8-positive T lymphocytes. These cytotoxic T cells surround and invade individual muscle fibres. This culminates in destruction of the muscle fibre. The attacked muscle fibres express class I (HLA-A, B, C) histocompatibility antigens. It is likely that the CD-8 positive T lymphocytes recognise muscular autoantigens as HLA-bound peptides. The active autoantigens are still unknown. In IBM - though not in PM - electron-microscopy reveals intranuclear and intracytoplasmic filaments that resemble myxoviruses. Hence, although it is possible that IBM is based on a virus infection, this has not been proved. Other investigations have shown interesting immunohistochemical similarities between IBM and Alzheimer's disease.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
[11]   Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution? [J].
Recher, Mike ;
Sahrbacher, Ulrike ;
Bremer, Juliane ;
Arndt, Boerge ;
Steiner, Urs ;
Fontana, Adriano .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) :469-472
[12]   FAST-TWITCH SARCOMERIC AND GLYCOLYTIC ENZYME PROTEIN LOSS IN INCLUSION BODY MYOSITIS [J].
Parker, Kenneth C. ;
Kong, Sek Won ;
Walsh, Ronan J. ;
Salajegheh, Mohammad ;
Moghadaszadeh, Behzad ;
Amato, Anthony A. ;
Nazareno, Remedios ;
Lin, Yin Yin ;
Krastins, Bryan ;
Sarracino, David A. ;
Beggs, Alan H. ;
Pinkus, Jack L. ;
Greenberg, Steven A. .
MUSCLE & NERVE, 2009, 39 (06) :739-753
[13]   Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets [J].
Haq, Syed A. ;
Tournadre, Anne .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (08) :818-825
[14]   Pathogenesis of muscle weakness in inflammatory myositis [J].
Dunga, Sai Kumar ;
Sundaram, T. G. ;
Kavadichanda, Chengappa G. .
INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (06) :99-111
[15]   Standard treatment for myositis and muscular dystrophies [J].
Schmidt, J. ;
Vorgerd, M. .
NERVENARZT, 2011, 82 (06) :723-+
[16]   Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use [J].
Chiu, Yvonne E. ;
Co, Dominic O. .
PEDIATRIC DERMATOLOGY, 2011, 28 (04) :357-367
[17]   PERMISSIVE ENVIRONMENT FOR B-CELL MATURATION IN MYOSITIS MUSCLE IN THE ABSENCE OF B-CELL FOLLICLES [J].
Salajegheh, Mohammad ;
Pinkus, Jack L. ;
Amato, Anthony A. ;
Morehouse, Chris ;
Jallal, Bahija ;
Yao, Yihong ;
Greenberg, Steven A. .
MUSCLE & NERVE, 2010, 42 (04) :576-583
[18]   Diagnostic delay of myositis: an integrated systematic review [J].
Namsrai, Tergel ;
Parkinson, Anne ;
Chalmers, Anita ;
Lowe, Christine ;
Cook, Matthew ;
Phillips, Christine ;
Desborough, Jane .
ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
[19]   Autoimmune myositis-Mechanism and therapy development [J].
Uruha, Akinori .
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (06) :279-288
[20]   Therapy of myositis [J].
Keck, A. D. ;
Walker, U. A. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (03) :227-+